{"altmetric_id":233112,"counts":{"readers":{"mendeley":31,"citeulike":0,"connotea":0},"total":{"posts_count":1},"f1000":{"unique_users_count":1,"unique_users":["F1000Prime"],"posts_count":1}},"citation":{"abstract":"In a randomized, phase 3 trial, sunitinib demonstrated superior efficacy over interferon-alfa as first-line therapy in patients with metastatic clear-cell renal cell carcinoma (RCC). On the basis of outcome data from that trial, the authors developed a nomogram for predicting the probability of 12-month progression-free survival for patients who received sunitinib therapy.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e93cf058f610002494","doi":"10.1002\/cncr.23776","first_seen_on":"2011-08-16T06:10:14+00:00","issns":["0008-543X"],"issue":"7","journal":"Cancer (0008543X)","last_mentioned_on":1227052800,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18720362"],"pmid":"18720362","pubdate":"2008-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Health Sciences","Medicine","Life Sciences","Biochemistry, Genetics and Molecular Biology"],"subjects":["neoplasms"],"title":"Prognostic nomogram for sunitinib in patients with metastatic renal cell carcinoma.","type":"article","volume":"113","mendeley_url":"http:\/\/www.mendeley.com\/research\/prognostic-nomogram-sunitinib-patients-metastatic-renal-cell-carcinoma"},"altmetric_score":{"score":1,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1},"context_for_score":{"all":{"total_number_of_other_articles":3629356,"mean":4.9352152798544,"rank":2016252,"this_scored_higher_than_pct":25,"this_scored_higher_than":939221,"rank_type":"exact","sample_size":3629356,"percentile":25},"similar_age_3m":{"total_number_of_other_articles":51727,"mean":4.6977638711673,"rank":22088,"this_scored_higher_than_pct":42,"this_scored_higher_than":21933,"rank_type":"exact","sample_size":51727,"percentile":42},"this_journal":{"total_number_of_other_articles":2772,"mean":7.2501104294478,"rank":1924,"this_scored_higher_than_pct":17,"this_scored_higher_than":491,"rank_type":"exact","sample_size":2772,"percentile":17},"similar_age_this_journal_3m":{"total_number_of_other_articles":85,"mean":2.2886904761905,"rank":41,"this_scored_higher_than_pct":38,"this_scored_higher_than":33,"rank_type":"exact","sample_size":85,"percentile":38}}},"demographics":{"users":{"mendeley":{"by_status":{"Unspecified":1,"Researcher":10,"Student  > Doctoral Student":2,"Student  > Ph. D. Student":4,"Student  > Postgraduate":4,"Other":6,"Professor":4},"by_discipline":{"Medicine and Dentistry":21,"Agricultural and Biological Sciences":5,"Computer Science":1,"Mathematics":1,"Unspecified":3}}},"geo":{"mendeley":{"US":1,"FR":1}}},"posts":{"f1000":[{"title":"Recommended in F1000 Prime","url":"https:\/\/f1000.com\/prime\/1127041","license":"public","citation_ids":[233112],"posted_on":"2008-11-19T00:00:00+00:00","f1000_classes":["new_finding"],"f1000_score":"2"}]}}